UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma risk and onset age

American Journal of Gastroenterology

Volumn 100, Issue 8, 2005, Pages 1758-1763

  Tseng, Chien Sen ^a   Tang, Kung Sheng ^b   Lo, Hoi Wan ^a   Ker, Chen Guo ^a   Teng, Hsiu Chen ^b   Huang, Ching Shan ^b  

^a YUAN'S GENERAL HOSPITAL   (Taiwan)

^b FOOYIN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCURONOSYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 1A7; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GENETICS; CANCER RISK; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; MALE; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; ALLELE; CASE CONTROL STUDY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; LIVER TUMOR; MIDDLE AGED; RISK FACTOR; TAIWAN; VIROLOGY;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALLELES; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUCURONOSYLTRANSFERASE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; TAIWAN;

EID: 25644439246     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2005.41857.x     Document Type: Article

References (31)

1. Bosch FX, Munoz N. Hepatocellular carcinoma in the world: Epidemiologic questions. In: Tabor E, DiBisceglie AM, Purcell RH, eds. Etiology, pathology, and treatment of hepatocellular carcinoma in North America. Advances in Applied Biotechnology Series, Vol. 13. The Woodlands, Texas: Portfolio Publishing, 1991:5-54.
2. Fattovich G, Giustina G, Schalm SW, et al. Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. Hepatology 1995;21:77-82.
3. Saito I, Miyamura T, Ohbayashi A, et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 1990;87:6547-9.
4. Bulatao-Jayme J, Almero EM, Castro CA, et al. A case-control dietary study of primary liver cancer risk from aflatoxin exposure. Int J Epidemiol 1982;11:112-9.
5. Yu MC, Mack T, Hanisch R, et al. Hepatitis, alcohol consumption cigarette smoking, and hepatocellular carcinoma in Los Angeles. Cancer Res 1983;43:6077-9.
6. Chen CJ, Yu MW, Liaw YF. Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol 1997;12:S294-308.
7. Radominska-Pandya A, Czernik PJ, Little J, et al. Structural and functional studies of UDP-glucuronosyltransferases. Drug Metab Rev 1999;31:817-99.
8. Harding D, Jeremiah SJ, Povey S, et al. Chromosomal mapping of a human phenol UDP-glucuronosyltransferase, GNTl. Ann Hum Genet 1990;54(Pt 1):17-21.
9. Gong QH, Cho JW, Huang T, et al. Thirteen UDP glycosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics 2001;11:357-68.
10. Strassburg CP, Strassburg A, Nguyen N, et al. Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGTlA, UGT2B) in human esophagus. Biochem J 1999;338(Pt 2):489-98.
11. Strassburg CP, Nguyen N, Manns MP, et al. Polymorphic expression of the UDP-glucuronosyltransferase UGT1A gene locus in human gastric epithelium. Mol Pharmacol 1998;54:647-54.
12. Strassburg CP, Nguyen N, Manns MP, et al. UDP-glucuronosyltransferase activity in human liver and colon. Gastroenterology 1999;116:149-60.
13. Guillemette C. Pharmacogenomics of human UDP-glucuronosyltransferase enzymes. Pharmacogenomics J 2003;3:136-58.
14. Grove AD, Kessler FK, Metz RP, et al. Identification of a rat oltipraz-inducible UDP-glucuronosyltransferase (UGT1A T) with activity towards benzo(a)pyrene-7,8-dihydrodiol. J Biol Chem 1997;272:1621-7.
15. Guillemette C, Ritter JK, Auyeung DJ, et al. Structural heterogeneity at the UDP-glucuronosyltransferase 1 locus: Functional consequences of three novel missense mutations in the human UGT1A7 gene. Pharmacogenetics 2000;10:629-44.
16. Zheng Z, Park JY, Guillemette C, et al. Tobacco carcinogen-SUGITA detoxifying enzyme UGT1A7 and its association with orolaryngeal cancer risk. J Natl Cancer Inst 2001;93:1411-8.
17. Vogel A, Kneip S, Barut A, et al. Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT17 gene. Gastroenterology 2001;121:1136-44.
18. Strassburg CP, Vogel A, Kneip S, et al. Polymorphisms of the human UDP-glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer. Gut 2002;50:851-6.
19. van der Logt EM, Bergevoet SM, Roelofs HM, et al. Genetic polymorphisms in UDP-glucuronosyltransferases and glutathione S-transferases and colorectal cancer risk. Carcinogenesis 2004;25:2407-15.
20. Ockenga J, Vogel A, Teich N, et al. UDP glucuronosyltransferase (UGTlA7) gene polymorphisms increase the risk of chronic pancreatitis and pancreatic cancer. Gastroenterology 2003;124:1802-08.
21. Huang MJ, Yang SS, Lin MS, et al. Polymorphisms of the uridine-diphopho-glucuronosyltransferase 1 A7 gene in Taiwan Chinese. World J Gastroenterology 2005;11:797-802.
22. Wang Y, Kato N, Hoshida Y, et al. UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma in Japanese patients with hepatitis C virus infection. Clin Cancer Res 2004;10:2441-6.
23. Chen CJ, Yu MW, Liaw YF. Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol 1997;12:S294-308.
24. Chen ZM, Liu BQ, Boreham J, et al. Smoking and liver cancer in China: Case-control comparison of 36,000 liver cancer deaths vs. 17,000 cirrhosis deaths. Int J Cancer 2003;107:106-12.
25. Mishkin SY, Farber E, Ho RK, et al. Evidence for the hormone dependency of hepatic hyperplastic nodules: inhibition of malignant transformation after exogenous 17 beta-estradiol and tamoxifen. Hepatology 1983;3:308-16.
26. Tai DI, Liaw YF. Natural history of hepatitis B and D virus infections. J Formos Med Assoc 1992;91 (Suppl 3):S203-7.
27. Sun CA, Chen HC, Lu CF, et al. Transmission of hepatitis C virus in Taiwan: Prevalence and risk factors based on a nationwide survey. J Med Virol 1999;59:290-6.
28. Lu SN, Lin TM, Chen CJ, et al. A case-control study of primary hepatocellular carcinoma in Taiwan. Cancer 1988;62:2051-5.
29. Chuang WL, Chang WY, Lu SN, et al. The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area. A case-control study. Cancer 1992;69:2052-4.
30. Sun CA, Farzadegan H, You SL, et al. Mutual confounding and interactive effects between hepatitis C and hepatitis B viral infections in hepatocellular carcinogenesis: A population-based case-control study in Taiwan. Cancer Epidemiol Biomarkers Prev 1996;5:173-8.
31. Lu SN, Lee CM, Changchien CS, et al. Excess mortality from hepatocellular carcinoma in an HCV-endemic township of an HBV-endemic country (Taiwan). Trans R Soc Trop Med Hyg 1999;93:600-2.